Crown Bioscience is a brand-new company record, and its full research profile isn't ready yet.
crownbio.comCrawled Oct 23, 2026
The page describes Crown’s AML PDX models, scalable 3D bone marrow niche platforms, and translational biomarker services for AML therapeutics.
The page describes Crown Bioscience’s platforms for accelerating cell therapy discovery and validation, including CAR-T and TCR-T therapies.
The page promotes OrganoidXplore for fast-tracking oncology research with 50 models screened in 6 weeks, delivering reproducible results.
Crown Bioscience 7th Annual Advancing Drug Discovery for Oncology Symposium
The page highlights corporate resources on databases, immuno-oncology, biomarkers, in vivo oncology, and organoids at the Poster Hall.
The page explains how Crown Bioscience advances oncology research through innovation and client partnerships in translational oncology.
The page invites applicants to join Crown Bioscience, a fast-paced, results-driven organization in translational oncology.
The page describes life sciences career opportunities at Crown Bioscience, focusing on translational oncology and preclinical and clinical research.
The page introduces Crown Bioscience’s leadership and Scientific Advisory Board, experts in drug discovery and development.
The page introduces Crown Bioscience’s Strategic and Scientific Teams, experts in drug discovery and development.
The page offers dedicated meetings to discuss Crown Bioscience’s data, with privacy assured.
The page offers dedicated meetings to discuss Crown Bioscience’s webinars and data.
Advance translational oncology with Crown Bioscience, a full-service CRO delivering comprehensive preclinical and oncology CRO services worldwide.
The page states Crown Bioscience’s commitment to client-focused decisions and responsible personal data handling.
